
Articles
-
1 month ago |
ft.com | Attracta Mooney |David Isenberg
The risk of a global trade war is “a very big concern” that would damage the world’s ability to tackle rising temperatures by limiting...
-
2 months ago |
ft.com | David Isenberg
House Democrats have urged Securities and Exchange Commission acting chair Mark Uyeda to “safeguard” the agency’s data and work from the...
-
2 months ago |
securitiesdocket.beehiiv.com | David Isenberg |Bruce Carton
Good morning! Here’s what’s up. Clips ✂️Coinbase Says S.E.C. Will Drop Crypto LawsuitThe cryptocurrency exchange Coinbase said on Friday that the Securities and Exchange Commission had agreed to drop its lawsuit against the company, lifting a legal cloud over the global crypto industry and signaling a broader retreat by federal regulators.
-
Oct 21, 2024 |
ard.bmj.com | Sofia Ferreira Azevedo |Antonia Valenzuela |Cristian Alejandro Benitez |David Isenberg
Delayed-start arms, such as in the phase 2 MYOJAK (NCT04208464, testing baricitinib, a JAK 1/2 inhibitor) and ARTEMIS (NCT01315938, testing abatacept, a CTLA-4 analogue that blocks the costimulatory signal mediated by the CD28-CD80/86 pathway) IIM clinical trials, randomise subjects to a briefer placebo-controlled phase either at the beginning or at the end of the trial. All subjects receive treatment which incentivises patient participation.
-
Oct 21, 2024 |
ard.bmj.com | Sofia Ferreira Azevedo |Antonia Valenzuela |Cristian Alejandro Benitez |David Isenberg
Delayed-start arms, such as in the phase 2 MYOJAK (NCT04208464, testing baricitinib, a JAK 1/2 inhibitor) and ARTEMIS (NCT01315938, testing abatacept, a CTLA-4 analogue that blocks the costimulatory signal mediated by the CD28-CD80/86 pathway) IIM clinical trials, randomise subjects to a briefer placebo-controlled phase either at the beginning or at the end of the trial. All subjects receive treatment which incentivises patient participation.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 558
- Tweets
- 17K
- DMs Open
- No

My latest article, courtesy of Washington Babylon. https://t.co/Oi8lAgOjJc

Is it just me, or doesn't anyone else see the resemblance between Melania Trump and Cad Bane? https://t.co/lot9WuYDbz

Do you remember when you joined X? I do! #MyXAnniversary https://t.co/OQXHvMUr5c